ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc (DNA)

10.83
0.63
(6.18%)
Cerrado 20 Enero 3:00PM
10.6106
-0.2194
(-2.03%)
Fuera de horario: 6:17PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
10.6106
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
1,194,622
9.99 Rango del Día 10.93
5.26 Rango de 52 semanas 64.40
Capitalización de Mercado [m]
Precio Anterior
10.20
Precio de Apertura
10.31
Última hora de negociación
Volumen financiero
US$ 12,544,750
Precio Promedio Ponderado
10.501
Volumen promedio (3 m)
1,311,671
Acciones en circulación
57,478,905
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.70
Beneficio por acción (BPA)
-15.53
turnover
251.46M
Beneficio neto
-892.87M

Acerca de Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Sector
Biological Pds,ex Diagnstics
Industria
Blank Checks
Sede
Wilmington, Delaware, USA
Fundado
2021
Ginkgo Bioworks Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the New York Stock Exchange with ticker DNA. The last closing price for Ginkgo Bioworks was US$10.20. Over the last year, Ginkgo Bioworks shares have traded in a share price range of US$ 5.26 to US$ 64.40.

Ginkgo Bioworks currently has 57,478,905 shares in issue. The market capitalisation of Ginkgo Bioworks is US$586.28 million. Ginkgo Bioworks has a price to earnings ratio (PE ratio) of -0.70.

Flujo de Opciones Ginkgo Bioworks (DNA)

Flujo General

Optimista

Prima Neta

680k

Calls / Puts

100.00%

Comp. / Vent.

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

DNA Últimas noticias

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors PR Newswire BOSTON, Jan. 13, 2025 Collaboration...

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire BOSTON, Jan. 9, 2025 BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA...

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program PR...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.1694-1.5714285714310.7810.8458.4412765189.29055067CS
42.150625.42080378258.4612.758.4141228210.06030963CS
122.620632.79849812277.9912.756.0113116719.13242126CS
26-3.8614-26.681868435614.47216.3925.26957884811.47027856CS
52-37.7894-78.077272727348.464.45.262478800627.07036396CS
156-213.7894-95.2715686275224.4255.25.262280220069.65732366CS
260-438.9894-97.6399911032449.6634.565.262142625284.98477101CS

DNA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ginkgo Bioworks?
El precio actual de las acciones de Ginkgo Bioworks es US$ 10.6106
¿Cuántas acciones de Ginkgo Bioworks están en circulación?
Ginkgo Bioworks tiene 57,478,905 acciones en circulación
¿Cuál es la capitalización de mercado de Ginkgo Bioworks?
La capitalización de mercado de Ginkgo Bioworks es USD 586.28M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ginkgo Bioworks?
Ginkgo Bioworks ha negociado en un rango de US$ 5.26 a US$ 64.40 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ginkgo Bioworks?
El ratio precio/beneficio de Ginkgo Bioworks es -0.7
¿Cuál es el ratio de efectivo a ventas de Ginkgo Bioworks?
El ratio de efectivo a ventas de Ginkgo Bioworks es 2.48
¿Cuál es la moneda de reporte de Ginkgo Bioworks?
Ginkgo Bioworks presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Ginkgo Bioworks?
El último ingresos anual de Ginkgo Bioworks es USD 251.46M
¿Cuál es el último beneficio anual de Ginkgo Bioworks?
El último beneficio anual de Ginkgo Bioworks es USD -892.87M
¿Cuál es la dirección registrada de Ginkgo Bioworks?
La dirección registrada de Ginkgo Bioworks es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Ginkgo Bioworks?
La dirección del sitio web de Ginkgo Bioworks es www.ginkgobioworks.com
¿En qué sector industrial opera Ginkgo Bioworks?
Ginkgo Bioworks opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ARLAmerican Realty Investors Inc
US$ 15.93
(15.02%)
10.76k
RBOTVicarious Surgical Inc
US$ 16.382
(14.88%)
52.57k
AUNAAuna SA
US$ 8.45
(14.81%)
233.16k
MYTEMYT Netherlands Parent BV
US$ 9.45
(12.23%)
354.61k
BKSYBlackSky Technology Inc
US$ 11.71
(12.06%)
1.7M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M
DMDesktop Metal Inc
US$ 2.19
(-9.88%)
547.32k
JKSJinkosolar Holdings Co Ltd
US$ 21.23
(-9.81%)
1.55M
BODIBeachbody Company Inc
US$ 6.60
(-9.59%)
19.82k
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
FFord Motor Company
US$ 10.18
(1.70%)
60.8M
BBDBanco Bradesco SA
US$ 1.96
(-1.01%)
59.92M
VALEVale SA
US$ 8.94
(1.94%)
59.4M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M

DNA Discussion

Ver más
ItsMyOption ItsMyOption 7 días hace
DNA just hit over sold area $8.70 that is .22 before the 1:40 R/S should go back up $11.00 soon
👍️0
Monksdream Monksdream 4 semanas hace
DNA under $10
👍️0
Monksdream Monksdream 1 mes hace
DNA, 10 day hourly
👍️ 1
PonkenPlonken PonkenPlonken 1 mes hace
cheap
👍️0
Monksdream Monksdream 3 meses hace
DNA under $10
👍️0
Monksdream Monksdream 4 meses hace
DNA 10 day hourly post reverse split
👍️0
hwang_jini hwang_jini 4 meses hace
Cascade (Gates) top holder
👍️0
Monksdream Monksdream 4 meses hace
DNA new. 52 w eek low
👍️0
Monksdream Monksdream 5 meses hace
DNA new 52/week low
👍️0
Monksdream Monksdream 5 meses hace
DNA new 52 week low
👍️0
Monksdream Monksdream 5 meses hace
DNA new 52 week low
👍️0
ItsMyOption ItsMyOption 5 meses hace
even after 1:40 R/S DNA still has too many shares outstanding and corporate insiders have poorly mismanaged the company.
Ginkgo Bioworks needs complete restructure and less corporate greed. Some of their founders sell shares daily as they where gifted too many.
I stopped buying long ago and waiting to see if management can get their act together - they all deserve a pay cut!
👍️ 1
Monksdream Monksdream 5 meses hace
DNA new 52 low
👍️0
Dingbatt Dingbatt 5 meses hace
Interesting stock bought a few for tracking
To see what the crawdads do
👍️0
ItsMyOption ItsMyOption 5 meses hace
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal

Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the “Officer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:

exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
👍️0
hwang_jini hwang_jini 6 meses hace
bio scam….

https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-hold-special-meeting-of-shareholders-302210173.html
👍️0
Acme Investments Acme Investments 7 meses hace
Sometimes I wonder if big names get kickbacks in exchange for their names being used??
👍️0
Acme Investments Acme Investments 7 meses hace
Cathy led her sheep 🐑 to slaughter!! Worst performing IPO I've ever seen!!
👍️ 1
Acme Investments Acme Investments 7 meses hace
😂😂😂😂😂😂😂
👍️0
trade2brich trade2brich 7 meses hace
ARK dumped all holdings. I am out. Cut my losses.
👍️0
Monksdream Monksdream 7 meses hace
It will reverse split because there is no choice
👍️0
JohnnyBlaze JohnnyBlaze 7 meses hace
Average down or cut losses?
👍️0
Monksdream Monksdream 7 meses hace
DNA new 52 week low
👍️0
Acme Investments Acme Investments 7 meses hace
Timber!!
👍️0
JohnnyBlaze JohnnyBlaze 7 meses hace
Bought a few
👍️0
Acme Investments Acme Investments 7 meses hace
R/S will be announced without warning!! Proceed with caution!!
👍️ 1
ItsMyOption ItsMyOption 7 meses hace
Yes, new low and very unhappy with DNA management. They were too slow to start restructuring and they still have one of the founders selling stock daily - what does he know?
👍️0
Monksdream Monksdream 7 meses hace
DNA new 52 week low
👍️0
Stump Jumper Stump Jumper 8 meses hace
I appreciate the response and opinion. I would like to think we would get a small bounce upward from here before a possible RS....
👍️0
philaya philaya 8 meses hace
Got in low...
Bounce ready.
👍️0
ItsMyOption ItsMyOption 8 meses hace
I feel we are close to bottom possible around.50 as lots of shorts took this down fast. We know DNA is in restructuring mode, which they should have done a long time ago. We still have one of their founders selling shares daily which should be in their ethic guidance as he most likely has inside info on R/S soon.

Long term I am positive but unhappy with management.
👍️0
Stump Jumper Stump Jumper 8 meses hace
Is this the bottom?
👍️0
Acme Investments Acme Investments 8 meses hace
Acknowledge Me!! Lol 😂
👍️0
wiredawg wiredawg 8 meses hace
Yep, yet another SPAC born public company that's in the toilet, I fore see a reverse announcement coming very soon, given they've received a listing standard Notice form the NYSE...
👍️0
Monksdream Monksdream 8 meses hace
DNA new 52 week low
👍️0
Acme Investments Acme Investments 8 meses hace
I'll take that as a no!! Lol 😂 The Cathy curse continues!!
👍️0
Acme Investments Acme Investments 8 meses hace
Still happy??
👍️0
ItsMyOption ItsMyOption 8 meses hace
Why DNA will keep going down is all the insider selling from page 43 of last finacials: Austin has been selling shares daily so it is founders driving the price below SEC requirements of min of $1.00
Ginkgo’s Founders currently own nearly 20% of the outstanding shares of Ginkgo, the vast majority of which are in Class B shares
? Class B shares are not freely tradable (must be converted to Class A) and are often not shown on automated data services
? As such, these aggregation services (such as Bloomberg or Yahoo) can be unhelpful in determining actual holdings of certain investors, including
our Founders, who may hold different classes of shares which may not be included

Founder sales through April 29, 2024 relative to total holdings(1)
Mandatory Sell-to-Cover(2) 10b5-1 plan
Shares sold
(in millions) % of holdings
Shares sold
(in millions) % of holdings
Jason (CEO) 12.3 11.3% 10.4 9.6%
Reshma (COO) 12.3 11.4% 1.9 1.8%
Barry (CTO) 12.3 11.2% 1.9 1.7%
Austin 12.3 11.3% 0.9 0.8
👍️0
Acme Investments Acme Investments 8 meses hace
Hope you took profits!! They just wanted to burn the shorts!!
👍️0
Acme Investments Acme Investments 8 meses hace
That's a lot of risk for 30%......Eventually you'll get snake eyes!!
👍️0
trade2brich trade2brich 8 meses hace
Bought at .70….up 30%
👍️0
Acme Investments Acme Investments 8 meses hace
Don't know if you noticed but Cathy has lost her MOJO and her investors a lot of money!! Proceed with caution ⚠!!
👍️0
trade2brich trade2brich 8 meses hace
ARK bought 12 million shares on Friday
👍️0
Acme Investments Acme Investments 8 meses hace
Ark is like the cattle whisperer!! Slaughter awaits!!
👍️0
Monksdream Monksdream 9 meses hace
DNA new 52 week low
👍️0
Monksdream Monksdream 9 meses hace
Aren’t you the smart one

👍️0
trade2brich trade2brich 9 meses hace
I did not I keep buying
👍️0
Monksdream Monksdream 9 meses hace
No, you buy
New 52 week lo
👍️0
trade2brich trade2brich 9 meses hace
Buy
👍️0
Monksdream Monksdream 9 meses hace
DNA new 52 lo

👍️0

Su Consulta Reciente

Delayed Upgrade Clock